Evidence map›Paper›PMID 25477714›Full record

ArticleMediators of inflammation2014

21-O-angeloyltheasapogenol E3, a novel triterpenoid saponin from the seeds of tea plants, inhibits macrophage-mediated inflammatory responses in a NF-κB-dependent manner.

Woo Seok Yang, Jaeyoung Ko, Eunji Kim, Ji Hye Kim, Jae Gwang Park, Nak Yoon Sung, Han Gyung Kim, Sungjae Yang, Ho Sik Rho, Yong Deog Hong and 2 more

Open access · goldAbstract read
In one paragraph

Article in Mediators of inflammation, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
1.3field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 38 citations in OpenAlex.

  1. Terpenoids fromPlants (Basel, Switzerland) · 2026
    Review
  2. Review
  3. Saponin from Tea (Molecules (Basel, Switzerland) · 2025
    Article
  4. Article
  5. Article
  6. Anti-International journal of molecular sciences · 2023
    Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Journal of ginseng research · 2017
    Article
  12. Article
  13. Article
  14. (E)-3-(3-methoxyphenyl)-1-(2-pyrrolyl)-2-propenone displays suppression of inflammatory responses via inhibition of Src, Syk, and NF-κB.The Korean journal of physiology & pharmacology : official journal of the Korean Physiological Society and the Korean Society of Pharmacology · 2016
    Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 2 institutions in 1 country.

Woo Seok YangDepartment of Genetic Engineering, Sungkyunkwan University, Suwon 440-746, Republic of Korea.
Jaeyoung KoMedical Beauty Research Institute, AmorePacific R&D Center, Yongin 446-729, Republic of Korea.
Eunji KimDepartment of Genetic Engineering, Sungkyunkwan University, Suwon 440-746, Republic of Korea.
Ji Hye KimDepartment of Genetic Engineering, Sungkyunkwan University, Suwon 440-746, Republic of Korea.
Jae Gwang ParkDepartment of Genetic Engineering, Sungkyunkwan University, Suwon 440-746, Republic of Korea.
Nak Yoon SungDepartment of Genetic Engineering, Sungkyunkwan University, Suwon 440-746, Republic of Korea.ORCID 0000-0001-8814-8701
Han Gyung KimDepartment of Genetic Engineering, Sungkyunkwan University, Suwon 440-746, Republic of Korea.
Sungjae YangDepartment of Genetic Engineering, Sungkyunkwan University, Suwon 440-746, Republic of Korea.ORCID 0000-0002-5513-5135
Ho Sik RhoMedical Beauty Research Institute, AmorePacific R&D Center, Yongin 446-729, Republic of Korea.
Yong Deog HongMedical Beauty Research Institute, AmorePacific R&D Center, Yongin 446-729, Republic of Korea.
Song Seok ShinMedical Beauty Research Institute, AmorePacific R&D Center, Yongin 446-729, Republic of Korea.
Jae Youl ChoDepartment of Genetic Engineering, Sungkyunkwan University, Suwon 440-746, Republic of Korea.ORCID 0000-0001-8141-9927
Sungkyunkwan University · KRAmorepacific (South Korea) · KR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

21-O-Angeloyltheasapogenol E3 (ATS-E3) is a triterpenoid saponin recently isolated from the seeds of the tea tree Camellia sinensis (L.) O. Kuntze. ATS-E3 has several beneficial properties including anti-inflammatory, antidiabetic, antiatherosclerotic, and anticancer effects. Unlike other phenolic compounds isolated from tea plants, there are no studies reporting the pharmacological action of ATS-E3. In this study, we therefore aimed to explore the cellular and molecular inhibitory activities of ATS-E3 in macrophage-mediated inflammatory responses. ATS-E3 remarkably diminished cellular responses of macrophages such as FITC-dextran-induced phagocytic uptake, sodium nitroprusside- (SNP-) induced radical generation, and LPS-induced nitric oxide (NO) production. Analysis of its molecular activity showed that this compound significantly suppressed the expression of inducible NO synthase (iNOS), nuclear translocation of nuclear factor- (NF-) κB subunits (p50 and p65), phosphorylation of inhibitor of κB kinase (IKK), and the enzyme activity of AKT1. Taken together, the novel triterpenoid saponin compound ATS-E3 contributes to the beneficial effects of tea plants by exerting anti-inflammatory and antioxidative activities in an AKT/IKK/NF-κB-dependent manner.

Indexed as

AnimalsAnti-Inflammatory AgentsCamellia sinensisCell LineHEK293 CellsHumansInflammationMacrophagesMiceNF-kappa BNitric OxideSaponinsSeedsSignal TransductionTriterpenes21-O-angeloyltheasapogenol E3Anti-Inflammatory AgentsNF-kappa BNitric OxideSaponinsTriterpenes

Identifiers

PMID25477714
PMCPMC4245502
OpenAlexW2054877334

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.